Form 4: Scholar Rock COO Executes Sell-to-Cover Transaction

Scholar Rock Holding Corp Chief Operating Officer Keith Woods sold 10,220 shares to satisfy tax obligations related to RSU vesting.

Summary

• Chief Operating Officer Keith Woods sold 10,220 shares of Scholar Rock Holding Corp common stock on April 16, 2026.
• The transaction was executed at an average price of $49.5745 per share.
• The sale was a mandatory 'sell-to-cover' transaction to satisfy tax withholding obligations resulting from the vesting of restricted stock units (RSUs).
• Following the transaction, the reporting person retains beneficial ownership of 620,055 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the transaction was purely administrative and mandatory for tax purposes rather than a discretionary sale.

Positives

• The transaction was non-discretionary and mandated by the issuer's equity incentive plan, indicating no change in management sentiment regarding the company's outlook.

Negatives

• The transaction results in a reduction of the executive's direct equity holdings.

Risks

• Future tax withholding requirements may necessitate further mandatory sell-to-cover transactions as additional RSUs vest.

Future Outlook

The filing does not provide forward-looking financial guidance, as it is a disclosure of an insider transaction.

Management Comments

• The sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a 'sell to cover' transaction.

Industry Context

StockSavvy.ai notes that mandatory sell-to-cover transactions are standard practice in the biotechnology sector for executives receiving equity-based compensation, and this filing does not signal a change in corporate strategy or insider confidence.

Comparison to Industry Standards

• The transaction aligns with standard corporate governance practices for equity compensation tax management in U.S. public companies.
• The use of 'sell-to-cover' is a common mechanism used by executives at firms like Amgen, Biogen, and other mid-cap biotech companies to manage tax liabilities.

Stakeholder Impact

• No material impact on shareholders, employees, or creditors as this is a routine tax-related transaction.

Next Steps

• Continued service of the reporting person to satisfy remaining vesting conditions for outstanding RSUs.

Key Dates

Keywords

Scholar Rock, SRRK, Form 4, Insider Trading, Sell-to-cover, Biotech